BioSpace News Archive

Excelra, a leading global data and analytics company, today announced the release of the COVID-19 Drug Repurposing Database (https://www.excelra.com/covid-19-drug-repurposing-database/).

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company Kannalife, Inc. (“Kannalife”) (OTCQB: KLFE),

Agion® Antimicrobial (AM) by Sciessent, a U.S.-based provider of antimicrobial (AM) solutions based on naturally occurring elements, is incorporated into FDA cleared N95 respirator masks, the type most in-demand in the fight against the COVID-19 pandemic.

Paradigm, the industry leader in solving catastrophic and complex health care challenges and improving lives, today announced a new COVID-19 solution designed to assist injured workers requiring medical care and support for recovery from the Coronavirus disease 2019 (COVID-19).

FUJIFILM Corporation (President: Kenji Sukeno) announces the initiation of a U.S. phase II clinical trial to evaluate the safety and efficacy of its influenza antiviral drug “Avigan® Tablet” (generic name: favipiravir) for patients with COVID-19, a respiratory infection caused by the novel SARS-CoV-2 coronavirus.

MedPresence® Telemedicine Solution Contributes to Physician Collaboration while Limiting Exposure for Staff and Patients

EicOsis LLC, a pharmaceutical startup developing a new class of oral non-narcotic analgesics based on inhibition of the soluble Epoxide Hydrolase (sEH) enzyme, announced today that the U.S. Food & Drug Administration (FDA) has granted Fast Track designation to its lead drug candidate, EC5026, for the treatment of neuropathic pain.

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ); (and hereafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (US FDA). Cipla’s Albuterol S

Orthofix Medical Inc. today announced preliminary financial results for the first quarter ended March 31, 2020 and provided a business update.

Glaukos Corporation today provided an update on the impact of the COVID-19 pandemic on the company and announced a preliminary net sales range for its first quarter of 2020. Preliminary and Unaudited First Quarter 2020 Net Sales and COVID-19